Users Online: 1436 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 


RSACP wishes to inform that it shall be discontinuing the dispatch of print copy of JOACP to it's Life members. The print copy of JOACP will be posted only to those life members who send us a written confirmation for continuation of print copy.
Kindly email your affirmation for print copies to dranjugrewal@gmail.com preferably by 30th June 2019.

 

 
Table of Contents
LETTER TO EDITOR
Year : 2013  |  Volume : 29  |  Issue : 3  |  Page : 421-423

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography


1 Department of Anaesthesiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
2 Department of Transfusion Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

Date of Web Publication27-Aug-2013

Correspondence Address:
Anupam Verma
Department of Transfusion Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0970-9185.117094

Rights and Permissions

How to cite this article:
Hemlata, Verma A, Elhence P. Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography. J Anaesthesiol Clin Pharmacol 2013;29:421-3

How to cite this URL:
Hemlata, Verma A, Elhence P. Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography. J Anaesthesiol Clin Pharmacol [serial online] 2013 [cited 2019 Sep 21];29:421-3. Available from: http://www.joacp.org/text.asp?2013/29/3/421/117094

Sir,

We read with interest a report by Glenn et al., [1] in which the authors assessed platelet function by platelet function analyzer (PFA) and standard thromboelastography (TEG) in a patient requiring epidural catheter removal as the patient had received an oral dose of clopidogrel and aspirin 72 hours earlier. As the results of both the tests were normal, removal of epidural catheter was allowed and authors concluded that 'PFA and TEG offer potentially reliable guidance for epidural catheter removal in patient who had received double antiplatelet therapy' (last paragraph pg 101).

However, we have some reservations if such conclusions can be drawn from their findings as antiplatelet response of aspirin and clopidogrel varies widely from one individual to another; with some having no response while some having bleeding. [2] Moreover, although PFA is a good screening tool for assessing platelet function, it is not recommended for monitoring of clopidogrel efficacy. [3] Also the 'standard TEG' used in the study is not sensitive to aspirin and clopidogrel drugs [4] and thus it can remain normal despite adequate platelet inhibition by aspirin and clopidogrel. While the modification of TEG, i.e., TEG-based platelet mapping (TEG ® -PlateletMapping™; Haemoscope, Niles, IL, USA) can quantify the contribution of fibrin, adenosine diphosphate (ADP) receptor and thromboxane A 2 (TxA 2 ) receptor in clot strength. [5] Hence it can assess the effect of individual antiplatelet agents namely, aspirin and clopidogrel, via inhibition of TxA 2 and ADP receptors, respectively. At our center we are using TEG-platelet mapping to quantify the effect of antiplatelet drugs in patients including those undergoing percutaneous cardiac intervention [Figure 1]. As illustrated in [Figure 1] apart from MA-thrombin (maximum possible clot strength), it also measures MA-fibrin (clot strength by fibrin alone), MA-ADP (clot strength under ADP receptor inhibition by clopidogrel), MA-AA (clot strength under TxA 2 receptor inhibition by aspirin) and thereafter the percentage (%) platelet inhibition is calculated. Thus platelet mapping measures platelet inhibition along with total platelet function as a reference point thereby assessing effect of antiplatelet agents more objectively.
Figure 1: TEG-platelet mapping tracings in a patient posted for angioplasty who has received loading doses of aspirin and clopidogrel. Panel 1 shows % TxA2 receptor inhibition by aspirin. Panel 2 shows % ADP receptor inhibition by clopidogrel

Click here to view


Hence, use of TEG-platelet mapping would have been more appropriate to quantify the platelet inhibition by antiplatelet drugs more objectively and would have helped authors in taking evidence based decision to discontinue or continue antiplatelet therapy both before surgery and also postoperatively to ascertain the optimum timing for catheter removal. Also decision to stop antiplatelet agents in a case with recent stenting before surgery should be based on a quantitative assessment of platelet function by a method which can assess platelet inhibition with combined drug therapy. Though, authors used two different point of care tests namely, TEG and PFA to ascertain hemostatic function in their patient however, both of these tests have their own limitations [3],[5] and TEG-platelet mapping alone would have been more appropriate in this setting. This is more so because TEG-platelet mapping assay could have been performed on the TEG analyzer using platelet-mapping kits.

 
  References Top

1.Glenn E, Mehl J, Rosinia FA, Liu H. Safe removal of an epidural catheter 72 hours after clopidogrel and aspirin administrations guided by platelet function analysis and thromboelastography. J Anaesthesiol Clin Pharmacol 2013;29:99-101.  Back to cited text no. 1
  Medknow Journal  
2.Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005;45:246-51.  Back to cited text no. 2
    
3.Michelson AD, Frelinger AL 3 rd , Furman MI. Current options in platelet function testing. Am J Cardiol 2006;98 (10A):4-10N.  Back to cited text no. 3
    
4.Hobson AR, Agarwala RA, Swallow RA, Dawkins KD, Curzen NP. Thrombelastography: Current clinical applications and its potential role in interventional cardiology. Platelets 2006;17:509-18.  Back to cited text no. 4
    
5.Agarwal S, Coakley M, Reddy K, Riddell A, Mallett S. Quantifying the effect of antiplatelet therapy: A comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry. Anesthesiology 2006;105:676-83.  Back to cited text no. 5
    


    Figures

  [Figure 1]


This article has been cited by
1 Assessment of Three Point-of-Care Platelet Function Assays in Adult Trauma Patients
C.R. Connelly,J.D. Yonge,S.P. McCully,K.D. Hart,T.C. Hilliard,D.E. Lape,J.J. Watson,B. Houser,T.G. Deloughery,M.A. Schreiber,L.N. Kiraly
Journal of Surgical Research. 2017;
[Pubmed] | [DOI]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
   References
   Article Figures

 Article Access Statistics
    Viewed2797    
    Printed33    
    Emailed0    
    PDF Downloaded448    
    Comments [Add]    
    Cited by others 1    

Recommend this journal